Sign in
Taking people in DenmarkPhase 4

Low-dose glucagon to prevent low blood sugar during exercise in type 1 diabetes

Tests low-dose glucagon before exercise in adults with type 1 diabetes using automated insulin delivery.

Key facts

Who runs it
Steno Diabetes Center Copenhagen
Where
Herlev, DenmarkSee the site
Registry title
The POST-PRANDIAL HYPO-AVOID STUDY Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People with Type 1 Diabetes
Status
Recruiting
Phase
Phase 4
People taking part
18 people, planned
Started
10 Apr 2026
Expected to end
1 May 2027
Type of study
Interventional
Record updated
16 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 1 diabetes who use an automated insulin delivery system. It tests low-dose glucagon before exercise after a meal.

Age
Older than 18 years
Sex
All sexes can join.
Disease stage
Type 1 diabetes for more than 2 years.
Earlier treatment
Must have used an automated insulin delivery system for 3 months or more. Must have been treated with NovoRapid or Fiasp for at least one week before joining.

Main reasons for not taking part

  • Allergy or past allergic reaction to lactose or glucagon
  • Pheochromocytoma, insulinoma or gastroparesis
  • Women of childbearing age who are pregnant, breast-feeding, planning pregnancy or not using adequate contraception
  • Other medical or psychological conditions that the investigator judges make taking part unsuitable
  • Cannot understand the information or give informed consent

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age more than 18 years old
  • Type 1 diabetes > 2 years
  • Use of automated insulin delivery system for equal to or more than 3 months
  • Treated with NovoRapid or Fiasp for at least one week priro to enrolment
  • Proefficiency in carbohydrate counting

Who cannot take part

  • Females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods (methods are considered adequate for study enrolment for females: an intrauterine device, hormonal contraception (birth control pills, implant, patch, vaginal ring or injection), a single partner who is sterile or infertile, or sexual abstinence. Contraception is required throughout the study duration. Sterilized or postmenopausal women (>12 months since last period) are not required to use contraception)
  • Allergies to lactose or glucagon
  • Known or suspected allergies to glucagon or related products
  • History of hypersensitivity or allergic reaction to glucagon or lactose
  • Concomitant medical or psychological conditions identified through review of medical history, physical examination and clinical laboratory analysis that, according to the investigator's assessment, makes the individual unsuitable for study participation
  • Patients with diagnosed pheochromocytoma, insulinoma or gastroparesis
  • Lack of compliance with key study procedures at the discretion of the investigator
  • Inability to understand the individual information and to give informed consent

Where in Denmark

  • Steno Diabetes Center CopenhagenHerlev, DenmarkTaking people

About the trial

What the trial wants to find out

To evaluate whether pre-exercise administration of low-dose subcutaneous glucagon prevents or attenuates exercise-induced declines in plasma glucose concentration during and after moderate-intensity continuous exercise (MICE) performed approximately 90 minutes after a meal in adults with type 1 diabetes using an automated insulin delivery (AID) system.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
The POST-PRANDIAL HYPO-AVOID STUDY Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People with Type 1 Diabetes
Plain-language title
Low-dose glucagon to prevent low blood sugar during exercise in type 1 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
16 March 2026